Mentho-Paraffinol Hasco

Liquid paraffin, the active ingredient in Mentho-Paraffinol Hasco, is a laxative presented as an oral liquid for oral use. It treats constipation by lubricating intestinal contents and is used in adults and children as directed by a healthcare professional.

GNH USA supplies Mentho-Paraffinol Hasco as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mentho-Paraffinol Hasco is a laxative indicated for disorders of bowel motility that result in difficulty passing stool.

- Occasional constipation: Softens hard stools and facilitates easier passage. - Chronic constipation: Provides regular bowel regulation when used over longer periods under medical supervision. - Constipation associated with opioid therapy: Helps counteract opioid‑induced reduced gastrointestinal motility.

Liquid paraffin is generally well tolerated, but some users may experience adverse reactions.

Common Side Effects: - Mild abdominal cramping - Flatulence or bloating - Nausea - Diarrhoea when used in excess - Rectal irritation

Serious or Rare Side Effects: - Lipid pneumonia from aspiration of the oil - Severe allergic reaction (anaphylaxis) - Persistent electrolyte imbalance with prolonged high‑dose use - Intestinal obstruction if taken without adequate fluid intake

When using Mentho-Paraffinol Hasco, consider the following safety measures.

- Assess suitability: Avoid in patients with known hypersensitivity to mineral oils. - Monitor fluid intake: Ensure adequate hydration to prevent hardening of the stool. - Use with caution in children: Follow pediatric guidance and avoid excessive doses. - Evaluate for obstruction: Discontinue if signs of bowel blockage appear. - Pregnancy and lactation: Consult a healthcare professional before use. - Store at ambient temperature: Keep below 25 °C, in the original container, protected from moisture and direct sunlight.

Liquid paraffin may interact with certain medications, altering their absorption or efficacy.

Major Interactions (Avoid): - Fat‑soluble vitamins (A, D, E, K): Reduced absorption leading to deficiency. - Lipid‑based oral medications (e.g., cyclosporine, certain antiretrovirals): Decreased bioavailability.

Moderate Interactions (Monitor Closely): - Antacids containing magnesium or aluminum: Potential for reduced efficacy of the laxative. - Diuretics: May exacerbate electrolyte loss if diarrhoea occurs. - Thyroid hormone replacement: Possible reduction in absorption; monitor thyroid levels.